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Twelve-month selective serotonin reuptake inhibitor treatment leads to sustained benefits for panicdisordered patients 1 year after medication discontinuation.
Background: The treatment of panic disorder using cognitive behavioral therapy (CBT) involves desensitization to feared bodily sensations that mimic or precede a panic attack, relearning a sense of safety through this process. Some researchers believe that this learning process is context dependent, such that a response to CBT provided with antidepressant therapy may not remain robust without medication. Objective: The authors of the next hypothesis sought to test this "context-safety hypothesis" by comparing the persisting effects of year-long CBT or selective serotonin reuptake inhibitor (SSRI) monotherapy with combined CBT and SSRI in panic-disordered patients before and after discontinuation of treatment. Participants/Methods: 150 patients with panic disorder were randomized to 1 of 3 treatments: CBT, SSRI, or CBT plus SSRI administered at 11 treatment sites in the Netherlands. Each treatment lasted approximately 1 year and was then tapered and discontinued. Clinicians chose between 5 SSRIs: paroxetine, sertraline, fluvoxamine, citalopram, and fluoxetine. CBT was administered by supervised students or experienced psychotherapists. Primary outcome measures were the clinician-rated Hamilton Anxiety Rating Scale (HARS) and the coping scale of the Panic Appraisal Inventory (PAI), a self report of confidence in managing future panic attacks. Remission was defined as the absence of panic attacks for at least 2 weeks and minimal anticipatory anxiety and agoraphobia. Data were collected before treatment, after treatment, and at 2 follow-up points in the year after discontinuation of treatment.
Results:
The retention rate in the 2-year study was 65%. Paroxetine, sertraline, and fluvoxamine were the most commonly prescribed antidepressants. The mean number of CBT sessions and psychopharmacology sessions were 19 and 12, respectively. After 9 months of treatment, SSRI treatment with and without CBT was superior to CBT monotherapy in HARS score. This difference abated in subsequent follow-up assessments. PAI coping scores decreased with all 3 treatments equally over time. There was no treatment effect on remitter status at any time point. Half of the sample had agoraphobia, which predicted poorer PAI scores after treatment. Daily benzodiazepine use also predicted poorer PAI scores after treatment.
Conclusions:
The use of SSRIs either alone or in combination with CBT led to a faster response than CBT alone, which caught up after 1 year of treatment. There was no drop-off in primary outcome measures after antidepressant discontinuation, contrary to the authors' hypothesis. Thus, both clinician-and patient-reported anxiety scores remained low even after treatment was discontinued, arguing against the so called "safetycontext hypothesis." Daily benzodiazepine use predicted poorer prognosis and should be avoided whenever possible in panic disorder. Reviewer's Comments: These results are reassuring to patients who seek rapid relief from panic symptoms that they may not be reliant on persistent antidepressant treatment to sustain gains after initial treatment. Larger studies are needed to replicate these findings. (Reviewer-Charlotte O. Ladd, MD, PhD).
Does DCS Enhance Learning by Activating Hippocampal Neurocircuits?
The N-Methyl-D-Aspartate Receptor Co-Agonist D-Cycloserine Facilitates Declarative Learning and Hippocampal Activity in Humans. While distinct neuropsychological features characterize individuals who are clinically high risk for conversion to a psychotic disorder, such a neuropsychological profile does not as yet appear a specific predictor of who might convert.
What Might Herald Conversion to Psychosis?
Background: Many domains of neuropsychological functioning have been shown to be important features of schizophrenia, especially with respect to verbal memory and processing speed. Neuropsychological deficits also appear in the premorbid stage among individuals who later develop the disease, and thus have been under study as potential markers to predict who will actually convert among individuals at risk for developing schizophrenia. Any effort to provide earlier treatment or develop preventive intervention for vulnerable individuals will require a reliable way to identify those most at risk to convert. Individuals at high risk for conversion have tended to be divided among those with strong familial-historical high-risk factors (FHR) and those with clinical high-risk factors (CHR) (ie, those having specific subsyndromal symptoms, such as isolated thought disorder, paranoia, unusual thinking, or unusual behaviors, etc). Objective: To look for the predictive value of profiles of neuropsychological deficits among both FHR and CHR individuals and assess whether such profiles differed across these groups. Methods: 8 centers specializing in these issues collaborated to recruit patients into this prospective study. Criteria for CHR and FHR were determined through standardized structured interviews and scoring for those purposes. Cognitive performance was assessed in CHR and FHR subjects, as well as comparison controls, through a comprehensive battery of neuropsychological testing performed at baseline. Individuals were then prospectively followed for 2.5 years and assessed for development of full DSM-IV psychotic disorder. Results: The FHR and CHR groups had comparable overall scored neuropsychological impairment, although the pattern of deficits differed. Verbal learning and memory and processing speed were more uniquely impaired in the CHR group compared to controls. Nonetheless, the pattern or severity of deficits did not independently predict greater likelihood of conversion in either group, although worse verbal memory did predict a more rapid time to conversion. Conclusions: While neuropsychological burdens are clearly present among CHR and FHR groups and show, in some ways, distinct patterns between them, such features predicted time to conversion but could not independently predict likelihood of conversion to a full disorder.
Reviewer's Comments:
This study is one of those rarities; it is the publishing of negative results. However, continuing efforts to refine understanding of the features that contribute to and herald the onset of psychotic illness will nonetheless benefit by this further filling in specific ways neuropsychological features evolve across risk groups over time. The details of the domains of impairment and their distribution across risk groups are worth reading in some detail in the accompanying article. (Reviewer-Gary S. Belkin, MD, PhD, MPH). Having posttraumatic stress disorder confers a substantially increased risk of subsequent development of dementia among affected U.S. veterans.
Toll of Combat on US Veterans Continues to Grow
Background: Posttraumatic stress disorder (PTSD) is a common risk among returning soldiers, but it is also a chronic condition. Among Vietnam veterans, apparently 10% to 15% had PTSD ≥15 years after their return from combat, and among WW II and Korean War veterans, combat-related PTSD prevalence was as high as 12% some 45 years later. Those chronic effects included greater health care use and the risk of a range of health conditions. There is reason to believe that among those long-term risks might be heightened occurrence of dementia given the possible effects of such a chronic condition on brain aging and neurophysiological integrity.
Objective: The authors used the medical databases of the Veterans Affairs health system to construct a cohort within which to compare onset of dementia rates among those with and those without PTSD at baseline. Methods: The VA National Patient Care Database was used to extract records on veterans who were ≥55 years of age between 1997 and 2000 without a baseline diagnosis of dementia and who had ongoing records for follow-up through 2007. The dataset allowed capture of all diagnoses and forms of care received by these individuals within the VA system during that time period as well as various sociodemographic characteristics, laboratory parameters, and other features, including key medical comorbidities (head injury, stroke, diabetes, substance use, hypertension, depression, etc), which are often associated as confounding risks for dementia. Results: A total of 181,093 veterans were followed; 53,155 had PTSD at baseline (mean age, 68.8 years). Veterans with PTSD had a 7-year cumulative incident rate of dementia of 10.6%. Those without PTSD had a cumulative incident rate of 6.6%, a statistically significant difference (P <0.001). After adjusting for confounding features including head injury history, substance use and depression, those with PTSD remained significantly more likely to develop dementia (risk ratio, 1.77).
Conclusions:
Having PTSD confers a substantially increased risk of subsequent development of dementia among affected U.S. veterans. Reviewer's Comments: This study supports a link between these conditions that if replicated, but particularly if confirmed through work that establishes compelling mechanisms that explain such a link, could provide a model for opening up new insights into the unfolding nature of environmental and biological interactions that lead to and connect a range of serious psychiatric conditions. (Reviewer-Gary S. Belkin, MD, PhD, MPH).
Tricks of the Trade --Habit Reversal Training for Tics
Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial. Piacentini J, Woods D, et al: JAMA 2010; 303 (May 19): 1929 303 (May 19): -1937 Habit reversal training, which includes relaxation training, is very effective in children with chronic tic disorders, such as Tourette.
Background: Prevalence estimates for Tourette disorder in school-aged children suggest a rate of 6 per 1000. Tics begin in childhood, with severity peaking in early adolescence and then declining in young adulthood. The most promising behavioral intervention for reducing tic severity is habit reversal training. The primary components of habit reversal training are tic awareness and competitive response training. Habit reversal teaches competitive response training, which involves engagement in a voluntary behavior physically incompatible with the tic. Rather than simply attempting to suppress the tic, the individual learns to tense certain muscle groups involved in the tic and do an alternative, barely perceptible, motion instead. Objective: To evaluate the efficacy of a comprehensive behavioral intervention for tics (CBIT) based on habit reversal training for reducing tics and tic-related impairment in a large sample of children and adolescents with Tourette disorder. Participants/Methods: 126 patients with Tourette or chronic tic disorder were randomized to either CBIT or control treatment in a 1:1 ratio. The control treatment consisted of supportive psychotherapy and education regarding tic disorders. Patients were permitted to continue medication treatment for tics as long as they were on a stable regimen, and the randomization took medication status into account. Overall, 36.5% of the participants were on anti-tic medication. Outcome assessments were repeated at weeks 5 and 10. The primary outcome measures were the Yale Global Tic Severity Scale and the Clinical Global Impressions-Improvement Scale.
Results: The Yale Global Tic Severity Scale Total Tic score was significantly reduced in the behavioral intervention group compared with the control group, with an effect size of 0.68. For behavior therapy, this difference reflects a number needed to treat of 3. Children randomized to behavioral intervention showed a 51% decrease on the Yale Global Tic Severity Scale-Impairment compared to a 30% decrease for the control treatment.
Conclusions: According to the authors, "A comprehensive behavioral intervention, compared with supportive therapy and education, resulted in greater improvement in symptom severity among children with Tourette and chronic tic disorder." Reviewer's Comments: Interestingly, at the 6-month follow-up point, 50% to 75% of the control group and 60% to 90% of the treatment group exhibited continued benefit. This lack of a large relapse rate in the control group suggests that even supportive therapy and psychoeducation can be beneficial to some patients with chronic tics. The improvement in actual tic severity, however, lies in the behavioral intervention group.
(Reviewer-John G. Koutras, MD).
